ChartOur World in Data

New drugs approved in the United States, by designations

Annual number of new drugs approved by the US Center for Drug Evaluation and Research that fall under each designation, including Orphan Drugs, Fast Track, Accelerated Approval, Breakthrough Therapy, and Qualified Infectious Disease Product.

Source
Our World in Data
Updated
16 Jul 2025
Last checked
17 Sept 2026
Rights status
Commercial use allowed
View source

Copy actions record publisher intent only. They do not confirm publication, citation or a backlink.

Data visualization: New drugs approved in the United States, by designations

Data visualization loaded directly from Our World in Data.

Reuse conditions

Usage rights

CC_BY
Source-hosted embed use
Allowed
Commercial use
Allowed
Modification
Allowed
Attribution
Required
Citation
Required
Raw-data redistribution
Allowed

Chart and embed permission is separate from raw-data redistribution. The raw dataset is not included in this marketplace asset unless that right is explicitly marked allowed.

View rights evidence

Publisher workflow

Exact citation

US Food and Drug Administration (2025)

Attribution: FDA

Source-hosted only

Embed instructions

<iframe src="https://citesupply.com/e/new-drugs-approved-in-the-united-states-by-designations" title="New drugs approved in the United States, by designations" loading="lazy" referrerpolicy="strict-origin-when-cross-origin" sandbox="allow-scripts" style="width:100%;height:720px;border:0;display:block"></iframe>

Embeds stay hosted by the source. Cite Supply records an aggregate iframe-load signal before redirecting to the reviewed source embed; it does not proxy or republish the chart.